| Alexander Judson Moore Ruby, MD | |
|
898 N Pacific Coast Hwy Ste 600, El Segundo, CA 90245-2747 | |
| (310) 379-2134 | |
| Not Available |
| Full Name | Alexander Judson Moore Ruby |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 9 Years |
| Location | 898 N Pacific Coast Hwy Ste 600, El Segundo, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366822348 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 125067303 (Illinois) | Secondary |
| 207P00000X | Emergency Medicine | A159865 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Tarzana Medical Center | Tarzana, CA | Hospital |
| College Medical Center | Long beach, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pacific Coast Emergency Medical Associates, Inc | 5092861054 | 13 |
News Archive
When dealing with a life-limiting illness, palliative care can improve the quality of life for patients and families.
A post-mortem analysis of brain tissue from people who had been diagnosed with post-traumatic stress disorder (PTSD) may help explain enduring mysteries about the disorder, such as why women are more susceptible to it and whether a dampened immune system response plays a role in dealing with stress, a team headed by Yale University researchers has found.
The National Institutes of Health has awarded two Baylor University researchers a $1.46 million grant to research and test new compounds that could help fight cancerous tumors.
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
The U.S. Food and Drug Administration (FDA) hasapproved Torisel (temsirolimus) for the treatment of a certain type of advanced kidney cancer known as renal cell carcinoma.
› Verified 5 days ago
| Entity Name | Tarzana Emergency Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235176702 PECOS PAC ID: 7113823014 Enrollment ID: O20040708001387 |
News Archive
When dealing with a life-limiting illness, palliative care can improve the quality of life for patients and families.
A post-mortem analysis of brain tissue from people who had been diagnosed with post-traumatic stress disorder (PTSD) may help explain enduring mysteries about the disorder, such as why women are more susceptible to it and whether a dampened immune system response plays a role in dealing with stress, a team headed by Yale University researchers has found.
The National Institutes of Health has awarded two Baylor University researchers a $1.46 million grant to research and test new compounds that could help fight cancerous tumors.
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
The U.S. Food and Drug Administration (FDA) hasapproved Torisel (temsirolimus) for the treatment of a certain type of advanced kidney cancer known as renal cell carcinoma.
› Verified 5 days ago
| Entity Name | Sherman Oaks Emergency Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518904150 PECOS PAC ID: 1557377736 Enrollment ID: O20060224000406 |
News Archive
When dealing with a life-limiting illness, palliative care can improve the quality of life for patients and families.
A post-mortem analysis of brain tissue from people who had been diagnosed with post-traumatic stress disorder (PTSD) may help explain enduring mysteries about the disorder, such as why women are more susceptible to it and whether a dampened immune system response plays a role in dealing with stress, a team headed by Yale University researchers has found.
The National Institutes of Health has awarded two Baylor University researchers a $1.46 million grant to research and test new compounds that could help fight cancerous tumors.
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
The U.S. Food and Drug Administration (FDA) hasapproved Torisel (temsirolimus) for the treatment of a certain type of advanced kidney cancer known as renal cell carcinoma.
› Verified 5 days ago
| Entity Name | Valley Presbyterian Emergency Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033133103 PECOS PAC ID: 1951308105 Enrollment ID: O20061031000344 |
News Archive
When dealing with a life-limiting illness, palliative care can improve the quality of life for patients and families.
A post-mortem analysis of brain tissue from people who had been diagnosed with post-traumatic stress disorder (PTSD) may help explain enduring mysteries about the disorder, such as why women are more susceptible to it and whether a dampened immune system response plays a role in dealing with stress, a team headed by Yale University researchers has found.
The National Institutes of Health has awarded two Baylor University researchers a $1.46 million grant to research and test new compounds that could help fight cancerous tumors.
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
The U.S. Food and Drug Administration (FDA) hasapproved Torisel (temsirolimus) for the treatment of a certain type of advanced kidney cancer known as renal cell carcinoma.
› Verified 5 days ago
| Entity Name | Pacific Coast Emergency Medical Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316179492 PECOS PAC ID: 5092861054 Enrollment ID: O20090917000115 |
News Archive
When dealing with a life-limiting illness, palliative care can improve the quality of life for patients and families.
A post-mortem analysis of brain tissue from people who had been diagnosed with post-traumatic stress disorder (PTSD) may help explain enduring mysteries about the disorder, such as why women are more susceptible to it and whether a dampened immune system response plays a role in dealing with stress, a team headed by Yale University researchers has found.
The National Institutes of Health has awarded two Baylor University researchers a $1.46 million grant to research and test new compounds that could help fight cancerous tumors.
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
The U.S. Food and Drug Administration (FDA) hasapproved Torisel (temsirolimus) for the treatment of a certain type of advanced kidney cancer known as renal cell carcinoma.
› Verified 5 days ago
| Entity Name | Telemedicine365, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912525817 PECOS PAC ID: 0648683920 Enrollment ID: O20210105001789 |
News Archive
When dealing with a life-limiting illness, palliative care can improve the quality of life for patients and families.
A post-mortem analysis of brain tissue from people who had been diagnosed with post-traumatic stress disorder (PTSD) may help explain enduring mysteries about the disorder, such as why women are more susceptible to it and whether a dampened immune system response plays a role in dealing with stress, a team headed by Yale University researchers has found.
The National Institutes of Health has awarded two Baylor University researchers a $1.46 million grant to research and test new compounds that could help fight cancerous tumors.
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
The U.S. Food and Drug Administration (FDA) hasapproved Torisel (temsirolimus) for the treatment of a certain type of advanced kidney cancer known as renal cell carcinoma.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexander Judson Moore Ruby, MD 898 N Pacific Coast Hwy Ste 600, El Segundo, CA 90245-2747 Ph: (310) 379-2134 | Alexander Judson Moore Ruby, MD 898 N Pacific Coast Hwy Ste 600, El Segundo, CA 90245-2747 Ph: (310) 379-2134 |
News Archive
When dealing with a life-limiting illness, palliative care can improve the quality of life for patients and families.
A post-mortem analysis of brain tissue from people who had been diagnosed with post-traumatic stress disorder (PTSD) may help explain enduring mysteries about the disorder, such as why women are more susceptible to it and whether a dampened immune system response plays a role in dealing with stress, a team headed by Yale University researchers has found.
The National Institutes of Health has awarded two Baylor University researchers a $1.46 million grant to research and test new compounds that could help fight cancerous tumors.
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
The U.S. Food and Drug Administration (FDA) hasapproved Torisel (temsirolimus) for the treatment of a certain type of advanced kidney cancer known as renal cell carcinoma.
› Verified 5 days ago
Monica E. Breedlove, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 390 N Pacific Coast Hwy Ste 3000, El Segundo, CA 90245 Phone: 818-287-7409 | |
Dr. Christopher Lee Hammond, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 898 N Pacific Coast Hwy Ste 600, El Segundo, CA 90245 Phone: 310-279-2134 | |
Dr. Sobiya Khan, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 390 N Pacific Coast Hwy Ste 3000, El Segundo, CA 90245 Phone: 917-656-9767 | |
Dr. Sara Levy, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1700 E Walnut Ave Ste 250, El Segundo, CA 90245 Phone: 213-748-2411 | |
Dale P Curtis, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2101 Rosecrans Ave Ste 3230, El Segundo, CA 90245 Phone: 323-628-8671 | |
Dr. John J Plosay Iii, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1700 E Walnut Ave, Suite 250, El Segundo, CA 90245 Phone: 800-882-9212 |